STOCK TITAN

Zynex Announces 1 Millionth Patient Milestone

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Argus Session date unavailable
+1.69% session move Open Argus
Details

News Market Reaction – ZYXI

The recorded move for ZYXI in the trading session of this news was +1.69%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

ENGLEWOOD, Colo., Aug. 10, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, announced that, since its founding, the company has treated more than 1 million patients through its pain management division.

Zynex manufactures and sells the NexWave electrotherapy device, an FDA-cleared, prescription-strength, non-invasive, and non-opioid approach to managing acute and chronic pain. The company's pain management division also distributes and private labels several high-quality devices such as low-back support, cervical traction, bracing, and hot/cold therapy. Zynex is bringing a series of in-patient hospital monitoring devices through FDA clearance in addition to its pain management and therapeutic products.

Thomas Sandgaard, Founder and CEO, commented on the company's milestone, "I'm incredibly proud to have surpassed treating 1 million patients. Reaching such a tremendous landmark for the company is a testament to the tireless efforts and teamwork that each of our employees brings to this company.

"Our journey to this moment has been filled with challenges, growth, and triumphs, and it's awe-inspiring to think about the countless lives we've touched. Success is not measured merely in numbers, but also in the positive change we've effected through proven non-opioid pain relief."

About Zynex, Inc.

Zynex, founded in 1996, develops, manufactures, markets, and sells medical devices used for pain management and rehabilitation as well as non-invasive fluid, sepsis, and laser-based pulse oximetry monitoring systems for use in hospitals. For additional information, please visit: www.zynex.com.

Investor Relations Contact:
Quinn Callanan, CFA or Brian Prenoveau, CFA
MZ Group – MZ North America
ZYXI@mzgroup.us
+949 694 9594

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/zynex-announces-1-millionth-patient-milestone-301897681.html

SOURCE Zynex

Keep reading